Edition:
United States

Teva Pharmaceutical Industries Ltd (TEVA.N)

TEVA.N on New York Stock Exchange

20.04USD
23 Feb 2018
Change (% chg)

$0.24 (+1.21%)
Prev Close
$19.80
Open
$19.94
Day's High
$20.14
Day's Low
$19.81
Volume
1,944,240
Avg. Vol
4,517,872
52-wk High
$36.19
52-wk Low
$10.85

Chart for

About

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic... (more)

Overall

Beta: 0.60
Market Cap(Mil.): $20,383.04
Shares Outstanding(Mil.): 1,014.36
Dividend: 0.09
Yield (%): 4.29

Financials

  Industry Sector
P/E (TTM): -- 30.98 16.31
EPS (TTM): -- -- --
ROI: -- 14.12 35.74
ROE: -- 15.72 17.71

BRIEF-Teva Announces Exclusive Launch Of Two Strengths Of A Generic Version Of Solodyn® In The United States

* TEVA ANNOUNCES EXCLUSIVE LAUNCH OF TWO STRENGTHS OF A GENERIC VERSION OF SOLODYN® IN THE UNITED STATES

Feb 20 2018

UPDATE 1-Drugmaker Hikma names former Teva exec Olafsson as CEO; shares up

Feb 20 Hikma Pharmaceuticals Plc named former Teva Pharmaceutical executive Sigurdur Olafsson as its CEO, as the Jordan-based drugmaker looks to improve its struggling generics business.

Feb 20 2018

Backstory: Warren Buffett's Valentine's Day surprise for investors

NEW YORK Warren Buffett had a Valentine’s Day surprise for investors in Teva Pharmaceutical Industries Ltd .   

Feb 16 2018

Berkshire buys Teva, feels IBM blues as Apple becomes top investment

Warren Buffett's Berkshire Hathaway Inc on Wednesday disclosed a new stake in generic drugmaker Teva Pharmaceutical Industries Ltd and said it bought more shares of Apple Inc , which surpassed Wells Fargo & Co as its largest common stock investment. | Video

Feb 15 2018

BRIEF-Paulson & Co Cuts Share Stake In Altaba, Dissolves in Teva

* PAULSON & CO CUTS SHARE STAKE IN ALTABA INC BY 56.1 PERCENT TO 1.7 MILLION SHARES - SEC FILING

Feb 14 2018

Berkshire buys Teva, bites more Apple, feels IBM blues

Feb 14 Warren Buffett's Berkshire Hathaway Inc on Wednesday said it has taken a new stake in Teva Pharmaceutical Industries Ltd, significantly boosted its holdings of Apple Inc and has nearly shed a less successful investment in IBM Corp.

Feb 14 2018

BRIEF-Berkshire Hathaway Takes Stake In Teva, Cuts in GM‍​

* BERKSHIRE HATHAWAY TAKES SPONSORED ADR STAKE IN TEVA PHARMACEUTICAL ‍​

Feb 14 2018

UPDATE 2-Novartis gains U.S. approval for delayed MS drug

* U.S. pricing pressure weighing on Sandoz (Adds Teva comment, share price reaction)

Feb 13 2018

Teva planned for second generic Copaxone to enter market in 2018

TEL AVIV Israel-based Teva Pharmaceutical Industries said on Tuesday it had anticipated and planned for a second generic competitor to its multiple sclerosis treatment Copaxone to enter the market in 2018.

Feb 13 2018

Teva planned for 2nd generic Copaxone to enter market in 2018

TEL AVIV, Feb 13 Israel-based Teva Pharmaceutical Industries said on Tuesday it had anticipated and planned for a second generic competitor to its multiple sclerosis treatment Copaxone to enter the market in 2018.

Feb 13 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF79.38 -0.60
Biogen Inc (BIIB.OQ) $292.78 +7.97

Earnings vs. Estimates